Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing Injection for prevention of ICU multidrug-resistant bacterial pneumonia
ChiCTR2500114884Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of tanreqing in bacterial pneumonia (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of multidrug-resistant bacterial pneumonia. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tanreqing
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on ChiCTR2500114884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114884.